메뉴 건너뛰기




Volumn 64, Issue 2, 2012, Pages 215-221

Diabetes mellitus risk in rheumatoid arthritis: Reduced incidence with anti-tumor necrosis factor α therapy

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ETANERCEPT; GLUCOCORTICOID; GOLIMUMAB; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

EID: 84858062113     PISSN: 00043591     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.20657     Document Type: Article
Times cited : (82)

References (40)
  • 2
    • 0347319155 scopus 로고    scopus 로고
    • Tumor necrosis factor-α production is associated with less body cell mass in women with rheumatoid arthritis
    • Walsmith J, Abad L, Kehayias J, Roubenoff R. Tumor necrosis factor-α production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol 2004;31:23-9. (Pubitemid 38067517)
    • (2004) Journal of Rheumatology , vol.31 , Issue.1 , pp. 23-29
    • Walsmith, J.1    Abad, L.2    Kehayias, J.3    Roubenoff, R.4
  • 3
    • 0036229685 scopus 로고    scopus 로고
    • Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?
    • DOI 10.1002/art.10089
    • Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extra articular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862-73. (Pubitemid 34303796)
    • (2002) Arthritis and Rheumatism , vol.46 , Issue.4 , pp. 862-873
    • Van Doornum, S.1    McColl, G.2    Wicks, I.P.3
  • 4
    • 0346365086 scopus 로고    scopus 로고
    • Explaining How "High-Grade" Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
    • DOI 10.1161/01.CIR.0000099844.31524.05
    • Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-63. (Pubitemid 37553561)
    • (2003) Circulation , vol.108 , Issue.24 , pp. 2957-2963
    • Sattar, N.1    McCarey, D.W.2    Capell, H.3    McInnes, I.B.4
  • 5
    • 0038167005 scopus 로고    scopus 로고
    • Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis
    • Dessein PH, Joffe BI, Stanwix AE. Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis. J Rheumatol 2003;30:1403-5. (Pubitemid 36835431)
    • (2003) Journal of Rheumatology , vol.30 , Issue.7 , pp. 1403-1405
    • Dessein, P.H.1    Joffe, B.I.2    Stanwix, A.E.3
  • 6
    • 84925548040 scopus 로고    scopus 로고
    • Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: Acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis
    • Dessein PH, Stanwix AE, Joffe BI. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 2002;4: R5.
    • (2002) Arthritis Res , vol.4
    • Dessein, P.H.1    Stanwix, A.E.2    Joffe, B.I.3
  • 8
    • 34247640820 scopus 로고    scopus 로고
    • Insulin resistance in patients with rheumatoid arthritis: Effect of anti-TNFα therapy
    • DOI 10.1080/03009740601179605, PII 778056640
    • Rosenvinge A, Krogh-Madsen R, Baslund B, Pedersen BK. Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNF α therapy. Scand J Rheumatol 2007;36:91-6. (Pubitemid 46685768)
    • (2007) Scandinavian Journal of Rheumatology , vol.36 , Issue.2 , pp. 91-96
    • Rosenvinge, A.1    Krogh-Madsen, R.2    Baslund, B.3    Pedersen, B.K.4
  • 9
    • 33845586799 scopus 로고    scopus 로고
    • Unstable diabetes in a patient receiving anti-TNF-α for rheumatoid arthritis [2]
    • DOI 10.1093/rheumatology/kel322
    • Boulton JG, Bourne JT. Unstable diabetes in a patient receiving anti-TNF-αfor rheumatoid arthritis [letter]. Rheumatology (Oxford) 2007;46:178-9. (Pubitemid 44932809)
    • (2007) Rheumatology , vol.46 , Issue.1 , pp. 178-179
    • Boulton, J.G.1    Bourne, J.T.2
  • 11
    • 34547631047 scopus 로고    scopus 로고
    • Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis
    • DOI 10.1007/s10067-007-0539-8
    • Tam LS, Tomlinson B, Chu TT, Li TK, Li EK. Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 2007;26:1495-8. (Pubitemid 47201685)
    • (2007) Clinical Rheumatology , vol.26 , Issue.9 , pp. 1495-1498
    • Tam, L.-S.1    Tomlinson, B.2    Chu, T.T.3    Li, T.K.4    Li, E.K.5
  • 12
    • 38449102126 scopus 로고    scopus 로고
    • Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis [letter]
    • Seriolo B, Paolino S, Ferrone C, Cutolo M. Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis [letter]. Clin Rheumatol 2007;26:1799-800.
    • (2007) Clin Rheumatol , vol.26 , pp. 1799-1800
    • Seriolo, B.1    Paolino, S.2    Ferrone, C.3    Cutolo, M.4
  • 13
    • 39549102650 scopus 로고    scopus 로고
    • Longterm anti-tumor necrosis factor-α treatment in patients with refractory rheumatoid arthritis: Relationship between insulin resistance and disease activity
    • Seriolo B, Ferrone C, Cutolo M. Longterm anti-tumor necrosis factor-α treatment in patients with refractory rheumatoid arthritis: relationship between insulin resistance and disease activity. J Rheumatol 2008;35:355-7. (Pubitemid 351281162)
    • (2008) Journal of Rheumatology , vol.35 , Issue.2 , pp. 355-357
    • Seriolo, B.1    Ferrone, C.2    Cutolo, M.3
  • 14
    • 33646445868 scopus 로고    scopus 로고
    • Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis
    • Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2006;33:921-3.
    • (2006) J Rheumatol , vol.33 , pp. 921-923
    • Kiortsis, D.N.1    Mavridis, A.K.2    Filippatos, T.D.3    Vasakos, S.4    Nikas, S.N.5    Drosos, A.A.6
  • 15
    • 17644393196 scopus 로고    scopus 로고
    • Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis
    • DOI 10.1136/ard.2004.026534
    • Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 2005;64:765-6. (Pubitemid 40559306)
    • (2005) Annals of the Rheumatic Diseases , vol.64 , Issue.5 , pp. 765-766
    • Kiortsis, D.N.1    Mavridis, A.K.2    Vasakos, S.3    Nikas, S.N.4    Drosos, A.A.5
  • 17
    • 79957526236 scopus 로고    scopus 로고
    • Hydroxychloroquine use is associated with improvement in lipid profiles in rheumatoid arthritis patients
    • Hoboken
    • Morris SJ, Wasko MC, Antohe JL, Sartorius JA, Kirchner HL, Dancea S, et al. Hydroxychloroquine use is associated with improvement in lipid profiles in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 2011;63:530-4.
    • (2011) Arthritis Care Res , vol.63 , pp. 530-534
    • Morris, S.J.1    Wasko, M.C.2    Antohe, J.L.3    Sartorius, J.A.4    Kirchner, H.L.5    Dancea, S.6
  • 18
    • 77956055481 scopus 로고    scopus 로고
    • 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European league against rheumatism collaborative initiative
    • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
    • (2010) Arthritis Rheum , vol.62 , pp. 2569-2581
    • Aletaha, D.1    Neogi, T.2    Silman, A.J.3    Funovits, J.4    Felson, D.T.5    Bingham III, C.O.6
  • 19
    • 75149130955 scopus 로고    scopus 로고
    • Diagnosis and classification of diabetes mellitus
    • American Diabetes Association
    • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl:S62-9.
    • (2010) Diabetes Care , vol.33 , Issue.SUPPL.
  • 20
    • 34247617640 scopus 로고    scopus 로고
    • Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: A pilot study
    • Dessein PH, Joffe BI, Stanwix AE. Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study. Arthritis Res 2002;4:R12.
    • (2002) Arthritis Res , vol.4
    • Dessein, P.H.1    Joffe, B.I.2    Stanwix, A.E.3
  • 23
    • 33751012122 scopus 로고    scopus 로고
    • Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    • Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006;33:2167-72. (Pubitemid 44749774)
    • (2006) Journal of Rheumatology , vol.33 , Issue.11 , pp. 2167-2172
    • Han, C.1    Robinson Jr., D.W.2    Hackett, M.V.3    Paramore, L.C.4    Fraeman, K.H.5    Bala, M.V.6
  • 24
    • 33847669745 scopus 로고    scopus 로고
    • Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older
    • Simard JF, Mittleman MA. Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older. J Rheumatol 2007;34:469-73. (Pubitemid 46363999)
    • (2007) Journal of Rheumatology , vol.34 , Issue.3 , pp. 469-473
    • Simard, J.F.1    Mittleman, M.A.2
  • 27
    • 0032729679 scopus 로고    scopus 로고
    • Mortality in rheumatoid arthritis: Have we made an impact in 4 decades?
    • Gabriel SE, Crowson CS, O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol 1999;26:2529-33.
    • (1999) J Rheumatol , vol.26 , pp. 2529-2533
    • Gabriel, S.E.1    Crowson, C.S.2    O'Fallon, W.M.3
  • 28
    • 77956503955 scopus 로고    scopus 로고
    • Explaining the cardiovascular risk associated with rheumatoid arthritis: Traditional risk factors versus markers of rheumatoid arthritis severity
    • Solomon DH, Kremer J, Curtis JR, Hochberg MC, Reed G, Tsao P 220 Antohe et al Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 2010;69:1920-5.
    • (2010) Ann Rheum Dis , vol.69 , pp. 1920-1925
    • Solomon, D.H.1    Kremer, J.2    Curtis, J.R.3    Hochberg, M.C.4    Reed, G.5    Tsao, P.6
  • 29
    • 0023500750 scopus 로고
    • Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity
    • DOI 10.1001/archinte.147.11.1912
    • Svenson KL, Lithell H, Hallgren R, Selinus I, Vessby B. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Intern Med 1987;147:1912-6. (Pubitemid 18003347)
    • (1987) Archives of Internal Medicine , vol.147 , Issue.11 , pp. 1912-1916
    • Svenson, K.L.G.1    Lithell, H.2    Hallgren, R.3    Selinus, I.4    Vessby, B.5
  • 30
    • 33749323030 scopus 로고    scopus 로고
    • Insulin resistance and impaired beta cell function in rheumatoid arthritis
    • DOI 10.1002/art.22053
    • Dessein PH, Joffe BI. Insulin resistance and impaired β cell function in rheumatoid arthritis. Arthritis Rheum 2006;54: 2765-75. (Pubitemid 44497755)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.9 , pp. 2765-2775
    • Dessein, P.H.1    Joffe, B.I.2
  • 31
    • 0027459878 scopus 로고
    • Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
    • Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α : direct role in obesitylinked insulin resistance. Science 1993;259:87-91. (Pubitemid 23036092)
    • (1993) Science , vol.259 , Issue.5091 , pp. 87-91
    • Hotamisligil, G.S.1    Shargill, N.S.2    Spiegelman, B.M.3
  • 32
    • 0028031569 scopus 로고
    • Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: Central role of tumor necrosis factor-α
    • Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α. J Clin Invest 1994;94:1543-9.
    • (1994) J Clin Invest , vol.94 , pp. 1543-1549
    • Hotamisligil, G.S.1    Budavari, A.2    Murray, D.3    Spiegelman, B.M.4
  • 36
    • 34147126829 scopus 로고    scopus 로고
    • The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk
    • Popa C, Netea MG, van Riel PL, van Der Meer JW, Stalenhoef AF. The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 2007;48:751-62.
    • (2007) J Lipid Res , vol.48 , pp. 751-762
    • Popa, C.1    Netea, M.G.2    Van Riel, P.L.3    Van Der Meer, J.W.4    Stalenhoef, A.F.5
  • 37
    • 25844456730 scopus 로고    scopus 로고
    • Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation
    • DOI 10.2337/diabetes.54.10.2939
    • Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK. Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 2005;54:2939-45. (Pubitemid 41401090)
    • (2005) Diabetes , vol.54 , Issue.10 , pp. 2939-2945
    • Plomgaard, P.1    Bouzakri, K.2    Krogh-Madsen, R.3    Mittendorfer, B.4    Zierath, J.R.5    Pedersen, B.K.6
  • 38
    • 36749076570 scopus 로고    scopus 로고
    • Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus [5]
    • DOI 10.1136/ard.2007.072256
    • Bonilla E, Lee YY, Phillips PE, Perl A. Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus [letter]. Ann Rheum Dis 2007;66:1688. (Pubitemid 350205467)
    • (2007) Annals of the Rheumatic Diseases , vol.66 , Issue.12 , pp. 1688
    • Bonilla, E.1    Lee, Y.Y.2    Phillips, P.E.3    Perl, A.4
  • 39
    • 34147167977 scopus 로고    scopus 로고
    • Improved insulin sensitivity by anti-TNFα antibody treatment in patients with rheumatic diseases [2]
    • DOI 10.1136/ard.2006.062323
    • Huvers FC, Popa C, Netea MG, van den Hoogen FH, Tack CJ. Improved insulin sensitivity by anti-TNF α antibody treatment in patients with rheumatic diseases [letter]. Ann Rheum Dis 2007;66:558-9. (Pubitemid 46580485)
    • (2007) Annals of the Rheumatic Diseases , vol.66 , Issue.4 , pp. 558-559
    • Huvers, F.C.1    Popa, C.2    Netea, M.G.3    Van Den Hoogen, F.H.J.4    Tack, C.J.5
  • 40
    • 79959426992 scopus 로고    scopus 로고
    • Association between disease-modifying ant rheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis
    • Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 2011;305:2525-31.
    • (2011) JAMA , vol.305 , pp. 2525-2531
    • Solomon, D.H.1    Massarotti, E.2    Garg, R.3    Liu, J.4    Canning, C.5    Schneeweiss, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.